| Specialty Retail Industry | Consumer Discretionary Sector | Steve N. Slilaty CEO | NASDAQ (CM) Exchange | 867781502 CUSIP |
| US Country | 50 Employees | - Last Dividend | - Last Split | 15 Feb 2022 IPO Date |
Sunshine Biopharma, Inc. is a forefront pharmaceutical company dedicated to the discovery, development, and commercialization of innovative life-saving medications for a variety of therapeutic domains, with a special focus on oncology and antivirals. The company is actively working on pioneering treatments designed to address some of the most challenging diseases, including various forms of cancer and viral infections. Based in New York, New York, Sunshine Biopharma is committed to improving patient outcomes through scientific excellence and a rigorous research and development process.